Skip to Main Content

The (POGO) Blog

March 3, 2017

By David S. Hilzenrath

Trump’s Dangerous Prescription for the FDA



President Trump addressing a joint session of Congress, with VP Mike Pence and Rep. Paul Ryan seated behind him, clapping. President Donald Trump called the FDA drug approval process slow and burdensome, but the evidence he cited could point to the opposite conclusion. Slashing regulatory restraints as he proposed could pose medical and financial hazards.

Continue Reading Trump’s Dangerous Prescription for the FDA

Topics: Government Accountability, Open Government, Public Health and Science

March 3, 2017

By Sean Moulton

Regulations: America’s Unsung Heroes



Man removing perscription drugs from cabinet President Trump should focus on making regulations better or improving the regulatory process. Regulations provide enormous benefits to all of us. For example, they ensure that prescription drugs and other products are safe for the public.

Continue Reading Regulations: America’s Unsung Heroes

Topics: Government Accountability, Agency Rulemaking

February 27, 2017

By Nick Schwellenbach

Private Prisons Are Back: Here's Why That's a Terrible Idea



Detention Center fence Attorney General Jeff Sessions reversed the Justice Department’s decision last year to phase out its use of private prisons, despite new reports raising concerns about their use.

Continue Reading Private Prisons Are Back: Here's Why That's a Terrible Idea

Topics: Contract Oversight

February 23, 2017

By Neil Gordon

Tracking Obama’s Corporate Crime Crackdown Coda



Violation Tracker logo over a backdrop of jail cells, original picture by Derek Key via Flickr Good Jobs First added to its Violation Tracker corporate misconduct database a flood of cases settled in the final weeks of the Obama administration, as well as enforcement data from nine more federal agencies.

Continue Reading Tracking Obama’s Corporate Crime Crackdown Coda

Topics: Government Accountability, Whistleblower Protections, Financial Sector, Contract Oversight

February 22, 2017

By Ned Feder, M.D.

Let There Be Light: The FDA's Surprising New Policy



FDA Shrouded in Darkness - the Food and Drug Administration building and sign The Food and Drug Administration has a brand-new policy bringing greater transparency regarding the agency's advisory committee members. The increased transparency will help address concerns over these members' conflicts of interest and the advice they giv

Continue Reading Let There Be Light: The FDA's Surprising New Policy

Topics: Government Accountability, Open Government, Public Health and Science

Items 11 - 15 of 100  Previous12345678910Next

Browse POGOBlog by Topic

POGO on Facebook

POGOBlog Contributors

See All Blog Contributors